For patients who experience a recurrence, traditional treatment options have been historically limited to either radiation or hormonal therapy. Mayo Clinic urologists, however, offer patients advanced clinical options, including novel treatments specifically for recurrent prostate cancer. Read the article.
Novel Treatments For Recurrent Prostate Cancer Read More »
Researchers are starting the world’s largest clinical trials to find out if aspirin can help prevent cancer relapse in the U.K. Although its potency is medically debated, if proven effective, this can be an efficient and cheapest anti-cancer drug. Read the article.
Aspirin And The Biggest Clinical Trial For Cancer In UK Read More »
Discovery could, among other things, slash the numbers of false negatives in PSA tests. Xiaohu Xia and his team, including researchers from Louisiana State University and the University of Texas at Dallas, have developed a new catalyst that could make lab tests like the PSA much more sensitive. Read the article.
New Catalyst Yields More Accurate PSA Test Read More »
A cheap test which can gauge the size of prostate cancer tumours has the potential to save thousands of lives each year, scientists believe The new test, which works like a pregnancy test, is twice as reliable as the current PSA blood test and would allow patients to find out in minutes whether they had cancer based on the levels of EN2 in their urine – a protein which is produced by tumours. Read the article.
Prostate cancer test that detects tumour size could save thousands of lives Read More »
Men who have an orgasm a day are lowering their risk of developing prostate cancer. A study has revealed that those men who ejaculate more often during their lifetime have a 22% lower risk of getting the disease. The study doesn’t give any reasons why the practice of ejaculation may help to stave off prostate cancer, but there are theories which have been made public previously. It has been thought that ejaculation can rid the prostate of cancer-causing chemicals, while there are also theories that if sperm is ‘cleaned out’ in this manner it can stop a build-up of old
Men who are sexually active ‘have lower risk of prostate cancer’ Read More »
Men receiving active surveillance were 24 times more likely to die from causes other than prostate cancer over 15 years. Caucasian men with favorable-risk prostate cancer who opt for active surveillance have a low risk of progression to lethal cancer for a decade after diagnosis, according to researchers. Read the article.
Prostate Cancer Deaths Rare Among Low-Risk Patients on Active Surveillance Read More »
New research has revealed that five different types of prostate cancer exist. World renowned robotic prostate cancer surgeon, Dr. David Samadi says this discovery may change the outlook of prostate cancer screening. “Discovering five different types of the disease could change how they’re distinguished from one another and may even mean different treatments for each, targeted to the individual patient,” said Dr. Samadi, Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital in New York City. Read the article.
New research finds five different types of prostate cancer Read More »
Scientists at the UW Carbone Cancer Center are in human trial phase for a vaccine to treat aggressive forms of prostate cancer. Scientists say this vaccine, combined with another drug, will help the body target prostate cancer cells. “We believe this vaccine has the potential to train a patient who has prostate cancer, to train their immune system to recognize the tumors that are growing as foreign and to begin to clear them and remove them from the body,” said Dr. Richard Lesniewski, the president and CEO of Madison Vaccines. Read the article.
University of Wisconsin researchers testing prostate cancer vaccine Read More »
Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter. In this Issue: Dr. Morton at our July Scotiabank Awareness Night Dr. Kell at our May Scotiabank Awareness Night Do It For Dads – the 2015 Father’s Day Walk/Run – with photos Ask the Doctor – Dr. Hamilton on PET scans Feedback from your Board of Directors Annual Volunteer Dinner Tell us what you think – take our website based survey 2015 Scotiabank Awareness Nights Schedule Read it by clicking the link below to open the pdf file: Sept_2015_Newsletter
Newsletter September 2015 Read More »
Chemotherapy at the start of hormone therapy can extend the lives of men with prostate cancer that has spread beyond the gland, a new study finds. Over nearly 29 months of follow-up, men with advanced prostate cancer who received the combination therapy lived almost 14 months longer than men who received only hormone therapy (58 months versus 44 months), researchers said. Read the article.
Adding chemotherapy to hormone therapy added 14 months to patients’ lives in study Read More »